This, together with our earlier reports showing an enhanced cancer cell-endothelial adhesion also resulting from the galectin-3-MUC1 interaction [12,27], indicates that the increased circulation of galectin-3 in the bloodstream of cancer patients promotes several important steps of the metastatic cascade. The gene discussed is MUC1; the disease is cancer.